IL24 and colorectal adenocarcinoma: Plasma IL-24 expression was robustly reduced in colorectal adenocarcinoma patients when compared with healthy controls (20.21 ± 8.15 ng/ml vs. 98.51 ± 18.94 ng/ml; Student's t-test, P < 0.0001, Figure 1A).